Review of psychotropic medication in Tasmanian residential aged care facilities

Australasian Journal on Ageing

Volumn 29, Issue 2, 2010, Pages 72-76

  Westbury, Juanita ^a   Beld, Karin ^a   Jackson, Shane ^a   Peterson, Gregory ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Antipsychotic; Benzodiazepine; Medication review; Psychotropic; Residential aged care facilities

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; AUSTRALIA; DRUG UTILIZATION; HOME FOR THE AGED; HUMAN; NURSING HOME; ORGANIZATION AND MANAGEMENT;

DRUG UTILIZATION; HOMES FOR THE AGED; HUMANS; NURSING HOMES; PSYCHOTROPIC DRUGS; TASMANIA;

EID: 77957104415     PISSN: 14406381     EISSN: 17416612     Source Type: Journal    
DOI: 10.1111/j.1741-6612.2010.00409.x     Document Type: Article

References (27)

1. Medical care of older persons in residential aged care facilities. 'Silver Book' National Taskforce 2006, http://www.racgp.org.au/guidelines, Royal Australian College of General Practitioners, 4th, edn., Available from URL:
2. Brodaty H, Draper B, Saab D. Psychosis, depression and behavioural disturbances in Sydney nursing home residents: Prevalence and predictors. International Journal of Geriatric Psychiatry 2001, 16:504-512.
3. The Use of Antipsychotics in Residential Aged Care. 2008, The Royal Australian and New Zealand College of Psychiatrists, Clinical recommendations developed by the RANZCP Faculty of Psychiatry of Old Age (New Zealand
4. Ballard C, Waite J, Birks J. Atypical antipsychotics for aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, 1. Art No.:CD003476
5. Schneider L, Tariot P, Dagerman K. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine 2006, 355:1525-1538.
6. Schneider L, Dagerman M, Insel P. Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomised, placebo-controlled trials. American Journal of Geriatric Psychiatry 2006, 14:191-210.
7. Madhusoodanan S, Bogunovic O. Safety of benzodiazepines in the geriatric population. Expert Opinion Patient Safety 2004, 3:485-493.
8. Education and Training Provided by Reconnexion. 2008, http://www.reconnexion.org.au, Reconnexion, [Cited 18 June 2009.] Available from URL:
9. Guidelines for the Rational Use of Benzodiazepines. 2000, http://www.racgp.org.au/guidelines/benzodiazepines, Royal Australian College of General Practitioners, [Cited 6 March 2009.] Available from URL:
10. Beier M, McHenry Martin C. Gradual dose reduction and medication tapering: A clinical perspective. Consultant Pharmacist 2007, 22:628-644.
11. Draper B, Brodaty H, Low L. Use of psychotropics in Sydney nursing homes: Associations with depression, psychosis, and behavioural disturbances. International Psychogeriatrics 2001, 13:107-120.
12. Roberts M, Stokes J, King J. Outcomes of a randomised controlled trial of a clinical pharmacy intervention in 52 nursing homes. British Journal of Clinical Pharmacology 2001, 51:257-265.
13. Snowdon J, Day S, Baker W. Current use of psychotropic medication in nursing homes. International Psychogeriatrics 2005, 17:1-10.
14. Nishtala P, McLachlan A, Bell J, Chen T. Psychotropic prescribing in long-term care facilities: Impact of medication reviews and educational interventions. The American Journal of Geriatric Psychiatry 2008, 16:621-632.
15. Feng Z, Hirdes J, Smith T. Use of physical restraints and antipsychotic medications in nursing homes: A cross-national study. International Journal of Geriatric Psychiatry 2009, 24:1110-1118. http://www.interscience.wiley.com, doi: 10.1002/gps.2232. [Cited 9 September 2009.] Available from URL:
16. Tucker M, Hosford I. Use of psychotropic medicines in residential care facilities for older people in Hawke's Bay, New Zealand. New Zealand Journal of Medicine 2008, 121:18-25.
17. Psychotherapeutic Medication in Australia: Report of the Senate Community Affairs References Committee 1995, Australian Senate, Canberra, Australian Government Printing Service
18. Ashton C. Benzodiazepines: How They Work, and How to Withdrawal. 2002, http://www.benzo.org.uk, [Cited 24 March 2009.] Available from URL:
19. Woods S. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 2003, 64:663-637.
20. Ballard C, Hanney M, Theodoulou M. The dementia antipsychotic withdrawal trial (DART-AD): Long -term follow-up of a randomised placebo-controlled trial. Lancet Neurology 2009, 8:151-157.
21. Hagen B, Armstrong-Esther C, Quail P. Neuroleptic and benzodiazepine use in long term care in urban and rural Alberta: Characteristics and results of an education intervention to ensure appropriate use. International Psychogeriatrics 2005, 17:631-652.
22. Selbaek G, Kirkevold O, Engedal K. The course of psychiatric and behavioural symptoms and the use of psychotropic medication in patients with dementia in norwegian nursing homes - a 12-month follow-up study. The American Journal of Geriatric Psychiatry 2008, 16:528-536.
23. Snowdon J, Vaughan R. Changes in psychotropic medication use in nursing homes over a 9-month period. Journal of Quality in Clinical Practice 1997, 17:83-90.
24. Gadzhanova S, Reed R. Medical services provided by general practitioners in residential aged-care facilities in Australia. Medical Journal of Australia 2007, 187:92-94.
25. Aged Care GP Panels Initiative. 2004 Aged Care Homes Survey 2005, http://www.health.gov.au/internet/main/publishing.nsf/Content/pcd-programs-acgppi-homesurvey, Ageing AGDoHa, Canberra, Ageing AGDoHa, [Cited 3 September 2009.] Available from URL:
26. Ballard C, Thomas A, Fossey J. A 3-month, randomised, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: The neuropsychiatric median cutoff is a predictor of clinical outcome. The Journal of Clinical Psychiatry 2004, 64:114-119.
27. Gilbert A, Owen N, Innes JM, Sansom L. Trial of an intervention to reduce chronic benzodiazepine use among residents of aged-care accommodation. Australia and New Zealand Journal of Medicine 1993, 23:243-247.